CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)

NCT01010061 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

787

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphocytic Leukemia, Chronic

Interventions

DRUG: obinutuzumab
DRUG: rituximab
DRUG: chlorambucil

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]
[object Object]